Med Immune v. PDL Bio Pharma

We were retained in this case by Gerson Zwifach and Paul Gaffney of Williams & Connolly LLP on behalf of their client, MedImmune. The case involved a suit by MedImmune against PDL claiming that it was overcharged and seeking recoupment of patent royalties previously paid on the respiratory drug Synapis. Compass Lexecon expert Daniel Rubinfeld filed four separate reports in the case on damages — ranging from patent infringement to various breach-of-contract claims — and was also deposed. The case recently settled for $92.5 million with MedImmune having no further obligation to make royalty payments. Professor Rubinfeld was supported by Daniel Ingberman who was assisted by Vijay Krishnan and Simon Rosen in the Oakland office.